TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
42 hedge funds and large institutions have $101M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
11
Reduced
9
Closed
9
Calls
$152K
Puts
$464K
Net Calls
-$312K
Net Calls Change
-$404K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$5.71M |
2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.09M |
3 |
![]()
3
Marshall Wace
London,
United Kingdom
|
$1.16M |
4 |
4
Renaissance Technologies
New York
|
$1.98M |
5 |
5
Two Sigma Investments
New York
|
$2.55M |
Top Sellers
1 |
1
Morgan Stanley
New York
|
$198K |
2 |
6CM
2
683 Capital Management
New York
|
$0 |
3 |
3
Millennium Management
New York
|
$426K |
4 |
SSA
4
Schonfeld Strategic Advisors
New York
|
$0 |
5 |
5
Goldman Sachs
New York
|
$0 |